Evaluation of breast surgical oncology complications after single agent versus dual agent HER2 targeted neoadjuvant chemotherapy

The aim of this study was to determine whether differing neoadjuvant chemotherapy (NAC) regimens for HER2 positive breast cancer (HER2+ BC) are associated with differing surgical complications. Our goal was to evaluate postoperative complications in HER2+ BC patients receiving NAC with Herceptin (trastuzumab, H) alone versus in combination with pertuzumab (HP).

Source: American Journal of Surgery - June 29, 2020 Category: Surgery Authors: Melissa Cullom, Amanda L. Amin, Christa R. Balanoff, Jamie L. Wagner, Kelsey E. Larson Source Type: research